Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Altern Complement Med ; 27(1): 80-87, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33074706

RESUMEN

Background: Ayurveda classifies human populations into three predominant groups as Vata, Pitta, and Kapha based on their "Prakriti'. Any disturbance in the equilibrium of Prakriti can cause various diseases. Objectives: The aim of the study was to link genotoxic variation among the three Prakriti having type 2 diabetes. Design: Type 2 diabetic patients and healthy individuals belonging to three predominant Prakriti were selected through the Prakriti Questionnaire screening as per the guidelines of the CSIR-TRISUTRA unit modified for type 2 diabetes disease. Settings/Location: Sixty individuals from three predominant Prakriti, each consisting of 10 diabetic patients and 10 healthy individuals, were chosen. Subjects: Clinically diagnosed outdoor patients of JBRMCH suffering from type 2 diabetes for 5 years (fasting blood glucose >140 mg/dL; HbA1C > 7.0) and healthy individuals were the subjects for study. Inclusion Criteria: Age limit: 30-70 years, Sex: Both, Habitant: Participants residing in West Bengal for the last five generations, Religion: Unspecified, Social entity: Both urban and rural, Education: High school to college, Economic status: Lower middle to middle classes. Exclusion Criteria: Participants were nonsmokers and nonalcoholics. An individual having a medical history of long-term illness or dwandaja Prakriti type was excluded here. Outcome Measures: Reactive oxygen species (ROS) generation, blood DNA content, DNA damage, apoptosis of blood cells, and interaction of DNA with various carcinogens were observed. Results: The yield of ROS and total cell damage were significantly higher in the diabetic Vata (p < 0.001) group compared with other Prakriti Decreased DNA content and increased DNA damage were observed in type 2 diabetic patients who belonged to Vata (p < 0.01) Prakriti. DNA of Vata Prakriti was more prone to lead and arsenic. Conclusions: The diabetic Vata Prakriti is a genetically susceptible group as it has a tendency to get affected by increased DNA damage, which could help in creating personalized management of diabetes among individual Prakriti.


Asunto(s)
Daño del ADN/genética , Diabetes Mellitus Tipo 2 , Medicina Ayurvédica , Adulto , Anciano , Apoptosis/fisiología , Células Sanguíneas/patología , Ensayo Cometa , ADN/sangre , Diabetes Mellitus Tipo 2/clasificación , Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/patología , Diabetes Mellitus Tipo 2/terapia , Femenino , Humanos , Masculino , Persona de Mediana Edad , Especies Reactivas de Oxígeno/sangre
2.
Integr Cancer Ther ; 17(3): 813-824, 2018 09.
Artículo en Inglés | MEDLINE | ID: mdl-29430988

RESUMEN

D-methionine is a sulfur-containing amino acid that can act as a potent antioxidant. Anorexia and nephrotoxicity are side effects of cisplatin. The protective effects of D-methionine on cisplatin-induced anorexia and renal injury were investigated. The model of chronic cisplatin administration (5 mg/kg body weight) involved intraperitoneal injection on days 1, 8, and 15 and oral D-methionine (300 mg/kg body weight) coadministration daily for 20 days. On the 21st day of treatment, food intake and body weight in the cisplatin-treated group significantly decreased by 52% and 31%, respectively, when compared with a control group. D-methionine coadministration with cisplatin decreased food intake and body weight by 29% and 8%, respectively. In cisplatin-treated rats, white blood cell, mean corpuscular volume, and platelet values significantly decreased, while mean corpuscular hemoglobin concentration significantly increased by 8.6% when compared with control rats. Cisplatin administration resulted in significantly decreased feeding efficiency, elevated renal oxidative stress, and reduced antioxidative activity. Leukocyte infiltration, tubule vacuolization, tubular expansion, and swelling were observed in the kidneys of cisplatin-treated rats. Oral D-methionine exhibited an antianorexic effect, with improvement in food intake, feeding efficiency, and hematological toxicities, as well as a protective effect against nephrotoxicity by elevated antioxidative activity. D-methionine may serve as a chemoprotectant in patients receiving cisplatin as part of a chemotherapy regimen.


Asunto(s)
Anorexia/inducido químicamente , Anorexia/prevención & control , Cisplatino/efectos adversos , Metionina/farmacología , Insuficiencia Renal Crónica/inducido químicamente , Insuficiencia Renal Crónica/prevención & control , Pérdida de Peso/efectos de los fármacos , Animales , Anorexia/sangre , Apetito/efectos de los fármacos , Recuento de Células Sanguíneas , Células Sanguíneas/efectos de los fármacos , Células Sanguíneas/patología , Cisplatino/administración & dosificación , Ingestión de Alimentos/efectos de los fármacos , Hemoglobinas/efectos de los fármacos , Hemoglobinas/metabolismo , Masculino , Metionina/administración & dosificación , Sustancias Protectoras/administración & dosificación , Sustancias Protectoras/farmacología , Ratas , Ratas Wistar , Insuficiencia Renal Crónica/sangre
3.
J Med Virol ; 90(4): 706-711, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29168885

RESUMEN

Spleen and kidney deficiency syndrome (SKD), a Traditional Chinese Medicine (TCM) syndrome, is the fundamental mechanisms of TCM. We aim to investigate the distribution of peripheral dendritic cells (DCs) in HBV patients with SKD or non-SKD. Peripheral venous blood from patients with HBV infection and healthy volunteers was collected to extract PBMC, and flow cytometry assay was used to measure the distribution of DCs subsets, including myeloid dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs). For the number of pDCs, it was higher in control group and non-SKD group, compared with HBV infection group and SKD group, respectively. For the number of mDCs, it was higher in control group and the non-SKD group compared to SKD group, while in control group it was higher than both HBeAg positive group and negative group. The number of pDCs in control group and chronic hepatitis B group were higher than HBVcarrier group, and it was higher in control group than both immune tolerance group and inactive group, while in immune clearance group it was higher than immune tolerance group and inactve group. The number of mDCs in control group and immune clearance group were higher than that of immune tolerance group. There was an obvious correlation between TCM syndromes and immune function in HBV infected patients, the number of pDCs and mDCs of the SKD group was lower than that in non-SKD group. These results provide a new insight into scientific evidence that TCM probably be based.


Asunto(s)
Células Dendríticas/inmunología , Hepatitis B Crónica/patología , Insuficiencia Renal/patología , Enfermedades del Bazo/patología , Adulto , Anciano , Células Sanguíneas/patología , Femenino , Citometría de Flujo , Hepatitis B Crónica/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Insuficiencia Renal/complicaciones , Enfermedades del Bazo/complicaciones , Adulto Joven
4.
Pharm Biol ; 55(1): 1937-1945, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28675957

RESUMEN

CONTEXT: Turmeric (Curcuma longa L. [Zingiberaceae]) is used in the treatment of a variety of conditions including pesticide-induced toxicity. OBJECTIVE: The study reports the antioxidant properties and the protective effects of turmeric against carbofuran (CF)-induced toxicity in rats. MATERIALS AND METHODS: The antioxidant potential was determined by using free radicals scavenging activity and ferric reducing antioxidant power values. Male Wistar rats were randomly divided into four groups, designated as control, turmeric (100 mg/kg/day), CF (1 mg/kg/day) and turmeric (100 mg/kg/day) + CF (1 mg/kg/day) treatments. All of the doses were administered orally for 28 consecutive days. The biological activity of the turmeric and CF was determined by using several standard biochemical methods. RESULTS: Turmeric contains high concentrations of polyphenols (8.97 ± 0.15 g GAEs), flavonoids (5.46 ± 0.29 g CEs), ascorbic acid (0.06 ± 0.00 mg AEs) and FRAP value (1972.66 ± 104.78 µM Fe2+) per 100 g of sample. Oral administration of CF caused significant changes in some of the blood indices, such as, mean corpuscular volume, corpuscular hemoglobin, white blood cell, platelet distribution width and induced severe hepatic injuries associated with oxidative stress, as observed by the significantly higher lipid peroxidation (LPO) levels when compared to control, while the activities of cellular antioxidant enzymes (including superoxide dismutase and glutathione peroxidase) were significantly suppressed in the liver tissue. DISCUSSION AND CONCLUSION: Turmeric supplementation could protect against CF-induced hematological perturbations and hepatic injuries in rats, plausibly by the up-regulation of antioxidant enzymes and inhibition of LPO to confer the protective effect.


Asunto(s)
Células Sanguíneas/efectos de los fármacos , Carbofurano/toxicidad , Curcuma , Hígado/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Antioxidantes/aislamiento & purificación , Antioxidantes/farmacología , Células Sanguíneas/metabolismo , Células Sanguíneas/patología , Relación Dosis-Respuesta a Droga , Eritrocitos/efectos de los fármacos , Eritrocitos/metabolismo , Eritrocitos/patología , Leucocitos/efectos de los fármacos , Leucocitos/metabolismo , Leucocitos/patología , Hígado/metabolismo , Hígado/patología , Masculino , Modelos Animales , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/fisiología , Extractos Vegetales/aislamiento & purificación , Distribución Aleatoria , Ratas , Ratas Wistar
5.
J Complement Integr Med ; 14(1)2017 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-28195548

RESUMEN

Pancytopenia is a health condition in which there is a reduction in the amount of leucocytes, erythrocytes and thrombocytes. If more than one of the blood cells is low then the condition is called as bicytopenia. The pancytopenic condition is observed in treatment of diseased conditions like thalassemia and hepatitis C. Iatrogenically pancytopenia is caused by some antibiotics and anti-HCV drugs. Medical conditions like aplastic anaemia, lymphoma, copper deficiency, and so forth can also cause pancytopenia. Pancytopenia can in turn decrease the immunity of the person and thereby can be fatal. Current therapies for pancytopenia include bone marrow stimulant drugs, blood transfusion and bone marrow transplant. The current therapies are very excruciating and have long-term side-effects. Therefore, treating these condition using herbal drugs is very important. Herbs like wheatgrass, papaya leaves and garlic are effective in treating single lineage cytopenias. The present review is focused on the potential effects of natural herbs for the treatment of pancytopenia.


Asunto(s)
Células Sanguíneas/patología , Magnoliopsida , Pancitopenia/tratamiento farmacológico , Fitoterapia , Extractos Vegetales/uso terapéutico , Médula Ósea , Humanos , Pancitopenia/etiología , Pancitopenia/terapia
6.
Pharm Biol ; 54(6): 964-74, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26971618

RESUMEN

CONTEXT: Pomegranate peel (PP) has health benefits including antibacterial, antioxidant, anti-inflammatory, and antimutagenic properties. OBJECTIVE: This study investigated the biochemical composition and protective effects of PP against hematotoxicity and genotoxicity induced by barium chloride (BaCl2) in adult rats. MATERIALS AND METHODS: Adult Wistar rats were divided into four groups of six each: control, barium (67 ppm via drinking water), PP (5% via diet), and their combination during 21 d. Oxidative stress was determined by MDA, AOPP, and antioxidant status: CAT, GPx, GSH, Vit C. Osmotic fragility (OF), chromosomal aberrations (CAs), and micronucleus (MN) assays were also studied. RESULTS: PP showed a rich composition of antioxidant compounds. DPPH test found IC50 value= 5.3 µg/mL and a high polysaccharides content (315 ± 5 mg/g of extract). In vivo study showed a decrease in red blood cells (70%) and platelet counts (46%), hemoglobin content (8%), hematocrit percent (7%), and an 80% increase of white blood cells in Ba-treated rats. A reduction in antioxidant status: catalase, glutathione peroxidase activities, glutathione, and vitamin C levels by 31, 21, 28, and 29%, respectively, and an increase in MDA (46%) and AOPP levels (72%) were also observed compared with controls. BaCl2-treatment showed a significant increase in the frequencies of total chromosomal aberrations with abnormal metaphases and micronucleus in bone-marrow cells. Oxidative stress induced by BaCl2 might be the major cause for chromosomal abnormalities leading to DNA damage. DISCUSSION AND CONCLUSION: A decrease in hematotoxic and genotoxic effects induced by PP is due to its powerful antioxidant capacity.


Asunto(s)
Antioxidantes/farmacología , Compuestos de Bario/toxicidad , Células Sanguíneas/efectos de los fármacos , Células de la Médula Ósea/efectos de los fármacos , Cloruros/toxicidad , Aberraciones Cromosómicas/efectos de los fármacos , Lythraceae/química , Animales , Antioxidantes/aislamiento & purificación , Compuestos de Bifenilo/química , Células Sanguíneas/metabolismo , Células Sanguíneas/patología , Proteínas Sanguíneas/metabolismo , Células de la Médula Ósea/metabolismo , Células de la Médula Ósea/patología , Aberraciones Cromosómicas/inducido químicamente , Femenino , Flavonoides/aislamiento & purificación , Flavonoides/farmacología , Micronúcleos con Defecto Cromosómico/inducido químicamente , Micronúcleos con Defecto Cromosómico/efectos de los fármacos , Fragilidad Osmótica/efectos de los fármacos , Picratos/química , Componentes Aéreos de las Plantas/química , Extractos Vegetales/química , Polisacáridos/aislamiento & purificación , Polisacáridos/farmacología , Ratas Wistar
7.
Br J Nutr ; 115(4): 619-28, 2016 Feb 28.
Artículo en Inglés | MEDLINE | ID: mdl-26678511

RESUMEN

As WHO recommends vitamin A supplementation (VAS) at vaccination contacts after age 6 months, many children receive VAS together with measles vaccine (MV). We aimed to investigate the immunological effect of VAS given with MV. Within a randomised placebo-controlled trial investigating the effect on overall mortality of providing VAS with vaccines in Guinea-Bissau, we conducted an immunological sub-study of VAS v. placebo with MV, analysing leucocyte counts, whole blood in vitro cytokine production, vitamin A status and concentration of C-reactive protein (CRP). VAS compared with placebo was associated with an increased frequency of CRP ≥ 5 mg/l (28 v. 12%; P=0·005). Six weeks after supplementation, VAS had significant sex-differential effects on leucocyte, lymphocyte, monocyte and basophil cell counts, decreasing them in males but increasing them in females. Mainly in females, the effect of VAS on cytokine responses differed by previous VAS: in previous VAS recipients, VAS increased the pro-inflammatory and T helper cell type 1 (Th1) cytokine responses, whereas VAS decreased these responses in previously unsupplemented children. In previous VAS recipients, VAS was associated with increased IFN-γ responses to phytohaemagglutinin in females (geometric mean ratio (GMR): 3·97; 95% CI 1·44, 10·90) but not in males (GMR 0·44; 95% CI 0·14, 1·42); the opposite was observed in previously unsupplemented children. Our results corroborate that VAS provided with MV has immunological effects, which may depend on sex and previous VAS. VAS may increase the number of leucocytes, but also repress both the innate and lymphocyte-derived cytokine responses in females, whereas this repression may be opposite if the females have previously received VAS.


Asunto(s)
Suplementos Dietéticos , Inmunidad Heteróloga , Leucocitos/inmunología , Vacuna Antisarampión/uso terapéutico , Sarampión/prevención & control , Deficiencia de Vitamina A/prevención & control , Vitamina A/uso terapéutico , Biomarcadores/sangre , Biomarcadores/metabolismo , Células Sanguíneas/citología , Células Sanguíneas/inmunología , Células Sanguíneas/metabolismo , Células Sanguíneas/patología , Células Cultivadas , Citocinas/sangre , Citocinas/metabolismo , Suplementos Dietéticos/efectos adversos , Femenino , Estudios de Seguimiento , Guinea Bissau/epidemiología , Humanos , Lactante , Recuento de Leucocitos , Leucocitos/citología , Leucocitos/metabolismo , Leucocitos/patología , Perdida de Seguimiento , Masculino , Sarampión/inmunología , Sarampión/metabolismo , Sarampión/patología , Vacuna Antisarampión/efectos adversos , Estado Nutricional , Prevalencia , Caracteres Sexuales , Vitamina A/efectos adversos , Deficiencia de Vitamina A/epidemiología , Deficiencia de Vitamina A/inmunología , Deficiencia de Vitamina A/metabolismo
8.
Transfus Apher Sci ; 53(2): 127-36, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26572801

RESUMEN

Capture assays were developed and validated for measuring the global pro-coagulant activity of micro-particles (MPs, mainly originated from platelets), or specific extravascular cellular MPs (released from erythrocytes, leukocytes, monocytes, endothelial cells) as those exposing TF (MP-TF, mainly observed in patients with some cancers). Conversely to Flow Cytometry methods, these capture assays measure all coagulant activity associated with MPs, through thrombin generation (MP-Activity) or Factor Xa generation (MP-TF), and therefore they bring a complementary information, as they are more specific for the pro-coagulant activity associated with MPs. Small particles (<0.40 µ) exposing Phosphatidyl Serine (PS) exhibit a greater pro-coagulant surface than larger MPs (0.40 to >1.00 µ), those preferentially measured with flow cytometry. Activity associated with MPs is a consequence of disease but can also be a cause contributing to pathological processes and development of thrombo-embolic events. In many diseases, flow cytometry and capture assays do not totally correlate, and have different associations with disease evolution. Optimized capture based assays are presented and discussed, along with their performance characteristics and some applications. They can be performed in any technically skillful hemostasis laboratory, using a thermostated ELISA equipment, or an incubator. Dynamic ranges for MP-Activity assay is from <0.1 nM to >2.5 nM Phospholipids, expressed as Phosphatidyl Serine (PS) equivalent, in the tested dilution. For MP-TF the very sensitive bio-immunoassay reported allows measuring concentrations from <0.10 pg/ml (TF equivalent) to >5.00 pg/ml, in the assayed dilution. No measurable MP-TF was found in normals, although an important concentration was generated from whole blood treated with Lipo-Poly-Saccharides. Capture based assays are then highly useful in the laboratory setting for measuring the activities associated with pro-coagulant, or specific cellular MPs.


Asunto(s)
Células Sanguíneas/metabolismo , Micropartículas Derivadas de Células/metabolismo , Neoplasias/sangre , Animales , Células Sanguíneas/patología , Micropartículas Derivadas de Células/patología , Ensayo de Inmunoadsorción Enzimática/métodos , Factor Xa/metabolismo , Humanos , Neoplasias/patología , Fosfatidilserinas/sangre
9.
Toxicol Mech Methods ; 24(8): 567-74, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25133553

RESUMEN

The Mimosa (Mimosa caesalpiniifolia) is a plant native from South America; it is used in the traditional medicine systems for treating bacterial, fungal, parasitic and inflammatory conditions. The aim of this study was to evaluate the antigenotoxic and antioxidant activities induced by mimosa (M. caesalpiniifolia) in multiple rodent organs subjected to intoxication with cadmium chloride. A total of 40 Wistar rats (8 weeks old, 250 g) were distributed into eight groups (n = 5), as follows: Control group (non-treated group, CTRL); Cadmium exposed group (Cd); cadmium exposure and treated with extract at 62.5 mg/kg/day; cadmium exposure and treated with extract at 125 mg/kg/day; cadmium exposure and treated with extract at 250 mg/kg/day; cadmium exposure and treated with ethyl acetate fraction at 62.5 mg/kg/day. For evaluating the toxicogenetic potential of mimosa, two groups were included in the study being treated with extract at 250 mg/kg/day and acetate fraction of mimosa at 62 mg/kg/day, only. Extract of mimosa at concentrations of 62.5 and 125 mg decreased DNA damage in animals intoxicated with cadmium when compared to cadmium group. In a similar manner, treatment with ethyl acetate fraction of mimosa at 62.5 mg concentration in animals previously exposed to cadmium reduced genetic damage in peripheral blood cells. In a similar manner, the treatment with ethyl acetate fraction reduced DNA damage in liver cells. Oxidative DNA damage was reduced to animals exposed to cadmium and treated with 125 mg of extract as well as those intoxicated to cadmium and treated with 62.5 of acetate fraction of mimosa. Taken together, our results indicate that mimosa prevents genotoxicity induced by cadmium exposure in liver and peripheral blood cells of rats as a result of antioxidant activity.


Asunto(s)
Antioxidantes/uso terapéutico , Intoxicación por Cadmio/tratamiento farmacológico , Daño del ADN/efectos de los fármacos , Mimosa/química , Fitoterapia , Extractos Vegetales/uso terapéutico , Hojas de la Planta/química , Acetatos/química , Animales , Antioxidantes/administración & dosificación , Antioxidantes/efectos adversos , Antioxidantes/aislamiento & purificación , Células Sanguíneas/efectos de los fármacos , Células Sanguíneas/metabolismo , Células Sanguíneas/patología , Brasil , Cloruro de Cadmio/antagonistas & inhibidores , Cloruro de Cadmio/toxicidad , Intoxicación por Cadmio/sangre , Intoxicación por Cadmio/metabolismo , Intoxicación por Cadmio/patología , Relación Dosis-Respuesta a Droga , Etnofarmacología , Hígado/efectos de los fármacos , Hígado/metabolismo , Medicina Tradicional , Mutágenos/química , Mutágenos/toxicidad , Estrés Oxidativo/efectos de los fármacos , Fitoterapia/efectos adversos , Extractos Vegetales/administración & dosificación , Extractos Vegetales/efectos adversos , Extractos Vegetales/aislamiento & purificación , Ratas Wistar , Solventes/química
10.
Oxid Med Cell Longev ; 2013: 486419, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24363823

RESUMEN

This study was conducted to investigate the modulating effects of green tea polyphenols on genotoxic damage and apoptotic activity induced by hexavalent chromium [Cr (VI)] in CD-1 mice. Animals were divided into the following groups: (i) injected with vehicle; (ii) treated with green tea polyphenols (30 mg/kg) via gavage; (iii) injected with CrO3 (20 mg/kg) intraperitoneally; (iv) treated with green tea polyphenols in addition to CrO3. Genotoxic damage was evaluated by examining micronucleated polychromatic erythrocytes (MN-PCEs) obtained from peripheral blood at 0, 24, 48, and 72 h after treatment. Induction of apoptosis and cell viability were assessed by differential acridine orange/ethidium bromide (AO/EB) staining. Treatment of green tea polyphenols led to no significant changes in the MN-PCEs. However, CrO3 treatment significantly increased MN-PCEs at 24 and 48 h after injection. Green tea polyphenols treatment prior to CrO3 injection led to a decrease in MN-PCEs compared to the group treated with CrO3 only. The average of apoptotic cells was increased at 48 h after treatment compared to control mice, suggesting that apoptosis could contribute to eliminate the DNA damaged cells induced by Cr (VI). Our findings support the proposed protective effects of green tea polyphenols against the genotoxic damage induced by Cr (VI).


Asunto(s)
Naranja de Acridina/metabolismo , Apoptosis/efectos de los fármacos , Células Sanguíneas/metabolismo , Cromo/toxicidad , Daño del ADN , Polifenoles/farmacología , Té/química , Animales , Células Sanguíneas/efectos de los fármacos , Células Sanguíneas/patología , Supervivencia Celular/efectos de los fármacos , Eritrocitos/efectos de los fármacos , Eritrocitos/metabolismo , Eritrocitos/patología , Etidio/metabolismo , Flavonoides/química , Flavonoides/farmacología , Masculino , Ratones , Pruebas de Micronúcleos , Extractos Vegetales/farmacología , Coloración y Etiquetado
11.
Food Chem Toxicol ; 59: 339-55, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23793040

RESUMEN

Ulcerative colitis affects many people worldwide. Inflammation and oxidative stress play a vital role in its pathogenesis. Previously, we reported that ulcerative colitis leads to systemic genotoxicity in mice. The present study was aimed at elucidating the role of α-lipoic acid in ulcerative colitis-associated local and systemic damage in mice. Experimental colitis was induced using 3%w/v dextran sulfate sodium in drinking water for 2 cycles. α-Lipoic acid was administered in a co-treatment (20, 40, 80 mg/kg bw) and post-treatment (80 mg/kg bw) schedule. Various biochemical parameters, histological evaluation, comet and micronucleus assays, immunohistochemistry and western blot analysis were employed to evaluate the effect of α-lipoic acid in mice with ulcerative colitis. The protective effect of α-lipoic acid was mediated through the modulation of nuclear factor kappa B, cyclooxygenase-2, interleukin 17, signal transducer and activator of transcription 3, nuclear erythroid 2-related factor 2, NADPH: quinone oxidoreductase-1, matrix metalloproteinase-9 and connective tissue growth factor. Further, ulcerative colitis led to an increased gut permeability, plasma lipopolysaccharide level, systemic inflammation and genotoxicity in mice, which was reduced with α-lipoic acid treatment. The present study identifies the underlying mechanisms involved in α-lipoic acid-mediated protection against ulcerative colitis and the associated systemic damage in mice.


Asunto(s)
Antioxidantes/uso terapéutico , Colitis Ulcerosa/prevención & control , Colon/efectos de los fármacos , Daño del ADN/efectos de los fármacos , Modelos Animales de Enfermedad , Estrés Oxidativo/efectos de los fármacos , Ácido Tióctico/uso terapéutico , Animales , Antioxidantes/administración & dosificación , Células Sanguíneas/efectos de los fármacos , Células Sanguíneas/inmunología , Células Sanguíneas/metabolismo , Células Sanguíneas/patología , Colitis Ulcerosa/inmunología , Colitis Ulcerosa/metabolismo , Colitis Ulcerosa/patología , Colon/inmunología , Colon/metabolismo , Colon/patología , Sulfato de Dextran , Relación Dosis-Respuesta a Droga , Fibrosis , Mediadores de Inflamación/sangre , Mediadores de Inflamación/metabolismo , Absorción Intestinal/efectos de los fármacos , Lipopolisacáridos/sangre , Lipopolisacáridos/metabolismo , Masculino , Ratones , Micronúcleos con Defecto Cromosómico/efectos de los fármacos , Tamaño de los Órganos/efectos de los fármacos , Permeabilidad/efectos de los fármacos , Distribución Aleatoria , Ácido Tióctico/administración & dosificación , Uniones Estrechas/efectos de los fármacos , Uniones Estrechas/inmunología , Uniones Estrechas/metabolismo , Uniones Estrechas/patología
12.
Vet Immunol Immunopathol ; 151(3-4): 303-14, 2013 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-23273932

RESUMEN

Bovine neonatal pancytopenia (BNP) is a recently described haemorrhagic disease of calves characterised by thrombocytopenia, leucopenia and bone marrow depletion. Feeding colostrum from cows that have previously produced a BNP affected calf has been shown to induce the disease in some calves, leading to the hypothesis that alloantibodies in colostrum from dams of affected calves mediate destruction of blood and bone marrow cells in the recipient calves. The aims of the current experimental study were first to confirm the role of colostrum-derived antibody in mediating the disease and second to investigate the haematopoietic cell lineages and maturation stages depleted by the causative antibodies. Clinical, haematological and pathological changes were examined in 5 calves given a standardised pool of colostrum from known BNP dams, and 5 control calves given an equivalent pool of colostrum from non-BNP dams. All calves fed challenge colostrum showed progressive depletion of bone marrow haematopoietic cells and haematological changes consistent with the development of BNP. Administration of a standardised dose of the same colostrum pool to each calf resulted in a consistent response within the groups, allowing detailed interpretation of the cellular changes not previously described. Analyses of blood and serial bone marrow changes revealed evidence of differential effects on different blood cell lineages. Peripheral blood cell depletion was confined to leucocytes and platelets, while bone marrow damage occurred to the primitive precursors and lineage committed cells of the thrombocyte, lymphocyte and monocyte lineages, but only to the more primitive precursors in the neutrophil, erythrocyte and eosinophil lineages. Such differences between lineages may reflect cell type-dependent differences in levels of expression or conformational nature of the target antigens.


Asunto(s)
Enfermedades de los Bovinos/inmunología , Calostro/inmunología , Isoanticuerpos/administración & dosificación , Isoanticuerpos/efectos adversos , Pancitopenia/veterinaria , Animales , Animales Recién Nacidos , Células Sanguíneas/inmunología , Células Sanguíneas/patología , Médula Ósea/inmunología , Médula Ósea/patología , Bovinos , Enfermedades de los Bovinos/sangre , Enfermedades de los Bovinos/patología , Linaje de la Célula/inmunología , Femenino , Genes MHC Clase II , Células Madre Hematopoyéticas/inmunología , Células Madre Hematopoyéticas/patología , Modelos Inmunológicos , Pancitopenia/inmunología , Pancitopenia/patología , Embarazo
13.
PLoS One ; 7(12): e52435, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23285041

RESUMEN

BACKGROUND: Heme oxygenase-1 (HO-1) is induced in many cell types as a defense mechanism against stress. We have investigated the possible role of endogenous HO-1 in the effector phase of arthritis using the K/BxN serum transfer model of arthritis in HO-1 heterozygous and homozygous knock-out mice. METHODOLOGY/PRINCIPAL FINDINGS: Arthritis was induced in C57/Black-6 xFVB (HO-1(+/+), HO-1(+/-) and HO-1(-/-)) mice by intraperitoneal injection of 150 µl serum from arthritic K/BxN mice at days 0 and 2. Blood was collected and animals were sacrificed at day 10. Histological analysis was performed in ankle sections. The levels of inflammatory mediators were measured in serum and paw homogenates by enzyme-linked immunosorbent assay or Multiplex technology. The incidence of arthritis was higher in HO-1(+/-) and HO-1(-/-) groups compared with HO-1(+/+). The inflammatory response was aggravated in HO-1(+/-) mice as shown by arthritic score and the migration of inflammatory cells that could be related to the enhancement of CXCL-1 production. In addition, the HO-1(+/-) group showed proteoglycan depletion significantly higher than HO-1(+/+) mice. Serum levels of matrix metalloproteinase-3, monocyte chemotactic protein-1, plasminogen activator inhibitor-1, E-selectin and intercellular adhesion molecule-1 were increased in arthritic HO-1(-/-) mice, whereas vascular endothelial growth factor and some cytokines such as interferon-γ showed a reduction compared to HO-1(+/+) or HO-1(+/-) mice. In addition, down-regulated gene expression of ferritin, glutathione S-reductase A1 and superoxide dismutase-2 was observed in the livers of arthritic HO-1(+/-) animals. CONCLUSION/SIGNIFICANCE: Endogenous HO-1 regulates the production of systemic and local inflammatory mediators and plays a protective role in K/BxN serum transfer arthritis.


Asunto(s)
Artritis Experimental/enzimología , Artritis Experimental/patología , Progresión de la Enfermedad , Hemo-Oxigenasa 1/metabolismo , Animales , Articulación del Tobillo/enzimología , Articulación del Tobillo/patología , Antioxidantes/metabolismo , Artritis Experimental/sangre , Artritis Experimental/genética , Células Sanguíneas/patología , Modelos Animales de Enfermedad , Regulación de la Expresión Génica , Mediadores de Inflamación/sangre , Masculino , Metaloproteinasa 3 de la Matriz/sangre , Ratones , Ratones Endogámicos C57BL , Osteocalcina/sangre , Ligando RANK/sangre , Factores de Tiempo
14.
Clin Immunol ; 138(1): 107-16, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21056009

RESUMEN

We analyzed peripheral blood (PB) and synovial fluid (SF) mononuclear cells from 16 rheumatoid arthritis (RA), 9 spondyloarthritis (SpA), 3 microcrystal arthritis patients, to define the presence of Th17 and Th1 and their relationship with inflammatory activity, and TCR-zeta chain and ZAP-70 levels. Th17 were significantly higher in SF than in PB and more abundant in microcrystal arthritis patients compared to the other groups. Irrespectively of the diagnosis, SF Th17 percentages correlated with joint (SF total leukocyte count, neutrophil percentage) and systemic (C reactive protein [CRP], fibrinogen, erythrocyte sedimentation rate) inflammation markers. SF Th1 percentages directly correlated with inflammation and disease activity (CRP, swollen joint count [SJC]) indices in SpA, but not in RA patients. These observations support the role of Th17 in the pathogenesis of inflammatory arthritides. The TCR-zeta(dim) lymphocytes in SF were found to produce the highest amounts of cytokines including IL-17, whereas no ZAP-70 impairment was associated to Th17.


Asunto(s)
Artritis/inmunología , Artritis/patología , Líquido Sinovial/citología , Células Th17/inmunología , Células Th17/patología , Adulto , Anciano , Anciano de 80 o más Años , Artritis/diagnóstico , Artritis/metabolismo , Células Sanguíneas/inmunología , Células Sanguíneas/patología , Sedimentación Sanguínea , Proteína C-Reactiva/metabolismo , Recuento de Células , Femenino , Fibrinógeno/metabolismo , Humanos , Inflamación/patología , Interferón gamma/metabolismo , Leucocitos/patología , Activación de Linfocitos/inmunología , Linfocitos/patología , Masculino , Persona de Mediana Edad , Monocitos/patología , Neutrófilos/patología , Receptores de Antígenos de Linfocitos T/metabolismo , Líquido Sinovial/inmunología , Líquido Sinovial/metabolismo , Células TH1/inmunología , Células TH1/metabolismo , Células TH1/patología , Células Th17/metabolismo , Proteína Tirosina Quinasa ZAP-70/metabolismo
15.
Hum Immunol ; 71(10): 931-3, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20650300

RESUMEN

The dendritic cell (DC) lineage encompasses a diverse population of cells with unique subtype-specific functions. In peripheral blood, four DC subsets have been identified based on their distinct expression of CD1c, CD141, CD16, and CD123, and these subpopulations exhibit functional properties in immune responses. However, their respective roles in allergic diseases, such as rhinitis, are unclear. In this study, we have performed comparative assessments of DC subset frequencies and investigated their FcεRI expression levels in patients with allergic rhinitis. We demonstrate that the frequencies of CD1c+ and CD141+ DCs are elevated in grass pollen-allergic subjects compared with healthy controls, irrespectively of allergen stimulation. Among the DC subsets, CD1c+ DCs expressed the highest levels of FcεRI mRNA, and a large proportion expressed surface FcεRI. Furthermore, the FcεRI expression levels were augmented upon allergen challenge. Thus our data suggest that CD1c+ DCs influence allergen-specific immune responses. Research on their functional properties in allergy is warranted for development of future immunotherapies targeting specialized DC subsets.


Asunto(s)
Células Sanguíneas/metabolismo , Células Dendríticas/metabolismo , Receptores de IgG/metabolismo , Rinitis Alérgica Estacional/inmunología , Alérgenos/efectos adversos , Antígenos CD/metabolismo , Antígenos de Diferenciación/metabolismo , Células Sanguíneas/inmunología , Células Sanguíneas/patología , Recuento de Células , Linaje de la Célula , Células Dendríticas/inmunología , Células Dendríticas/patología , Humanos , Inmunización , Inmunofenotipificación , Análisis por Micromatrices , Phleum , Polen/efectos adversos , Receptores de IgG/genética , Receptores de IgG/inmunología , Rinitis Alérgica Estacional/fisiopatología
16.
J Environ Pathol Toxicol Oncol ; 29(1): 69-79, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20528748

RESUMEN

The present study was undertaken to investigate the radiation mitigating effect of hydro-alcoholic extract of Saraca indica (SIE) against mice exposed to whole body gamma radiation. Free radical scavenging ability by SIE was demonstrated using hydroxyl, superoxide anion, ABTS*+ and DPPH radicals generated in vitro. A significant increase in the animal survival (dose reduction factor = 1.39), inhibition in the decline of hematological parameters as well as increased number of spleen colony-forming units was observed when SIE was administered prior to radiation. SIE pretreatment increased the levels of glutathione, glutathione S- trans-ferase, catalase and lowered lipid peroxidation. Our findings for the first time demonstrate the protective potential of SIE against radiation induced syndromes with an optimal dose of 400 mg/kg b.wt. The radiation mitigating effect may be attributed to the mechanisms such as free radical scavenging, elevation in antioxidant status, and reduction in lipid peroxidation.


Asunto(s)
Caesalpinia/química , Depuradores de Radicales Libres/farmacología , Extractos Vegetales/farmacología , Protectores contra Radiación/farmacología , Animales , Células Sanguíneas/efectos de los fármacos , Células Sanguíneas/patología , Células Sanguíneas/efectos de la radiación , Cromatografía Líquida de Alta Presión , Ensayo de Unidades Formadoras de Colonias , Relación Dosis-Respuesta en la Radiación , Evaluación Preclínica de Medicamentos , Femenino , Depuradores de Radicales Libres/química , Rayos gamma , Glutatión/metabolismo , Peroxidación de Lípido , Longevidad/efectos de los fármacos , Masculino , Ratones , Oxidorreductasas/metabolismo , Extractos Vegetales/química , Protectores contra Radiación/química , Bazo/efectos de los fármacos , Células Madre/efectos de los fármacos , Pruebas de Toxicidad Aguda , Irradiación Corporal Total/efectos adversos
17.
PLoS One ; 3(10): e3593, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18974832

RESUMEN

Chronic myeloid leukemia (CML) is characterized by the presence of a constitutively active Abl kinase, which is the product of a chimeric BCR-ABL gene, caused by the genetic translocation known as the Philadelphia chromosome. Imatinib, a selective inhibitor of the Bcr-Abl tyrosine kinase, has significantly improved the clinical outcome of patients with CML. However, subsets of patients lose their response to treatment through the emergence of imatinib-resistant cells, and imatinib treatment is less durable for patients with late stage CML. Although alternative Bcr-Abl tyrosine kinase inhibitors have been developed to overcome drug resistance, a cocktail therapy of different kinase inhibitors and additional chemotherapeutics may be needed for complete remission of CML in some cases. Chlorambucil has been used for treatment of B cell chronic lymphocytic leukemia, non-Hodgkin's and Hodgkin's disease. Here we report that a DNA sequence-specific pyrrole-imidazole polyamide-chlorambucil conjugate, 1R-Chl, causes growth arrest of cells harboring both unmutated BCR-ABL and three imatinib resistant strains. 1R-Chl also displays selective toxicities against activated lymphocytes and a high dose tolerance in a murine model.


Asunto(s)
Proliferación Celular/efectos de los fármacos , Clorambucilo/farmacología , Proteínas de Fusión bcr-abl/genética , Nylons/farmacología , Animales , Antineoplásicos Alquilantes/administración & dosificación , Antineoplásicos Alquilantes/farmacología , Secuencia de Bases/efectos de los fármacos , Benzamidas , Células Sanguíneas/metabolismo , Células Sanguíneas/patología , Células de la Médula Ósea/metabolismo , Células de la Médula Ósea/fisiología , Células Cultivadas , Clorambucilo/administración & dosificación , Clorambucilo/química , Evaluación Preclínica de Medicamentos , Proteínas de Fusión bcr-abl/metabolismo , Humanos , Mesilato de Imatinib , Leucemia Mielógena Crónica BCR-ABL Positiva/patología , Ratones , Modelos Biológicos , Nylons/química , Piperazinas/administración & dosificación , Piperazinas/farmacología , Pirimidinas/administración & dosificación , Pirimidinas/farmacología , Especificidad por Sustrato/efectos de los fármacos , Transducción Genética
18.
Eur J Hum Genet ; 16(7): 804-11, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18301449

RESUMEN

Germline mutations in mismatch repair (MMR) genes, tumours with high microsatellite instability (MSI-H) and loss of MMR protein expression are the hallmarks of HNPCC (Lynch syndrome). While somatic MLH1 promoter hypermethylation is generally accepted in the tumorigenesis of sporadic tumours, abnormal MLH1 promoter methylation in normal body cells is controversially discussed as a mechanism predisposing patients to HNPCC. In all 94 patients suspected of HNPCC-syndrome with a mean age of onset of 45.5 years, MLH1-deficiency in their tumours but no germline mutation, underwent methylation-specific PCR-screening for MLH1 promoter methylation. In peripheral blood cells of 12 patients an MLH1 promoter methylation, in seven informative cases allele-specific, was found. Normal colonic tissue, buccal mucosa, and tumour tissue available from three patients also presented abnormal methylation in the MLH1 promoter. The heredity of aberrant methylation is questionable. Pro: MLH1 promoter methylation was found in a patient and his mother giving evidence for a familial predisposition for an epimutation in MLH1. Contra: a de novo set-up of methylation in one patient, a mosaic or incomplete methylation pattern in six patients, and no evidence for inheritance of MLH1 promoter methylation in the remaining families. Our findings provide strong evidence that MLH1 promoter methylation in normal body cells mimics HNPCC and constitutes a pathogenic pre-lesion in MLH1. The identification of hypermethylation as an epigenetic defect has important implications for surveillance recommendations, as these patients should be treated like Lynch syndrome patients, whereas the heritability of methylation is still under investigation.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/genética , Células Sanguíneas/patología , Neoplasias Colorrectales Hereditarias sin Poliposis/genética , Metilación de ADN , Patrón de Herencia/genética , Mutación/genética , Proteínas Nucleares/genética , Regiones Promotoras Genéticas/genética , Alelos , Secuencia de Bases , Islas de CpG/genética , Análisis Mutacional de ADN , ADN Complementario/genética , ADN de Neoplasias/genética , Familia , Femenino , Humanos , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Homólogo 1 de la Proteína MutL , Fenotipo , Sulfitos/metabolismo
19.
J Med Toxicol ; 3(4): 146-51, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18072167

RESUMEN

INTRODUCTION: We evaluated the sub-chronic toxicity of the aqueous herbal extract prepared from Cassytha filiformis and administered daily for 28 days at dose levels (250, 500, and 1000 mg/kg bw) in male wistar albino rats. The LD50 of the aqueous extract was determined. METHODS: The effects on body weights, organ weights, and certain haematological and plasma biochemical parameters were measured as indices of organ toxicity. RESULTS: The aqueous extract did not affect plasma glutamate oxaloacetate transaminase (GOT) and glutamate pyruvate transaminase (GPT); however, a significant reduction in alkaline phosphatase (ALP) level occurred in all the treated groups. It also did not affect the electrolytes (Na , Cl and K ), total and direct bilirubin, creatinine, and glucose level. The aqueous extract elicited hypercholesterolaemic effects, but it did not affect the Hb, WBC, RBC, PVC, platelets, MCH, MCHC, MCV levels and differential counts (lympocytes, neutrophils, monocytes, eosinophils and basophils). It also reduced the body weight gain and absolute weight of the kidneys. The relative weights of the heart and lungs in some animal groups were equally reduced. The acute toxicological evaluation of the plant extract revealed an oral LD50 value greater than 500 mg/kg bw. CONCLUSION: This study suggests that aqueous extract of C. filiformis administered at normal therapeutic doses is not likely to produce severe toxic effects on some organs or haematological and biochemical indices in rats.


Asunto(s)
Células Sanguíneas/efectos de los fármacos , Lauraceae/química , Medicinas Tradicionales Africanas , Extractos Vegetales/toxicidad , Plantas Medicinales/química , Fosfatasa Alcalina/sangre , Animales , Células Sanguíneas/patología , Pruebas de Química Clínica , Recuento de Leucocitos , Masculino , Ratones , Componentes Aéreos de las Plantas , Ratas , Ratas Wistar , Pruebas de Toxicidad
20.
Chin J Integr Med ; 13(1): 22-6, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17578313

RESUMEN

OBJECTIVE: To study the effects of Jianpi Qingre Huayu Recipe in curing gastric ulcer and to preliminarily probe into its pathogenic mechanism. METHODS: Fifty patients with gastric ulcer of Pi -insufficiency and stasis-heat syndrome type were assigned to the treated group (30 patients) and the control group (20 patients). They were treated respectively with JQH and Ranitidine. At the same time, another group consisting of 20 healthy persons was set up for normal control. The clinical effect on gastroscopic figure and traditional Chinese medicine (TCM) syndrome were observed. Changes of T-cell subsets and interleukin-8 (IL-8) in serum as well as IL-8 in mucosa around the gastric ulcer were determined before and after treatment by flow cytometry and ELISA. RESULTS: Comparison of the total effective rate on gastroscopic figure in the treated group and the control group (86.7% vs 80.0%) showed insignificant difference, but the cure rate and markedly effective rate in the former (50.0% and 20.0%) was higher than that in the latter (40.0% and 15.0%) respectively. Comparison of the total effective rate on TCM syndrome in the treated group and in the control group (96.7% vs 70.0%) showed insignificant difference, but the cure rate and markedly effective rate in the former (63.3% and 23.3%) was higher than that in the latter (50.0% and 20.0%) respectively. Serum levels of CD3+, CD4+, CD8+ got restored to normal range in the treated group after treatment but it was not so in the control group. IL-8 level in gastric mucosa was improved in both groups but the improvement in the treated group was better. CONCLUSION: JQH could effectively treat gastric ulcer and partly reduce its recurrence through improving patients' immune function.


Asunto(s)
Medicamentos Herbarios Chinos/uso terapéutico , Úlcera Gástrica/terapia , Adulto , Antiulcerosos/uso terapéutico , Células Sanguíneas/patología , Ensayo de Inmunoadsorción Enzimática , Femenino , Citometría de Flujo , Mucosa Gástrica/metabolismo , Gastroscopía , Humanos , Sistema Inmunológico/patología , Sistema Inmunológico/fisiopatología , Interleucina-8/sangre , Interleucina-8/metabolismo , Masculino , Persona de Mediana Edad , Ranitidina/uso terapéutico , Úlcera Gástrica/diagnóstico , Úlcera Gástrica/inmunología , Úlcera Gástrica/metabolismo , Subgrupos de Linfocitos T/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA